Stemline Therapeutics Inc. (STML) Surged 16.83% or 1.86 To Price $12.91 On Tuesday


Stemline Therapeutics Inc. (STML) surged 16.83% or 1.86 to $12.91. It is approximately 1.37 million shares traded, which is 251.4% compare to the average total volume 544711. The market cap of STML is $410.55 million. The year to date change is 28.79%. The 52 week price range is from $7.82 to $20.55. Price of STML have changed -7.69% during last week. It have changed -2.56% over last month, 4.05% over last 3 months, -31.58% over last 6 months and -36.49% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for STML is 10.78. It is -16.50% below current price. The 200-day Moving Averages for STML is 14.24. It is 10.30% above current price. The 52-week High is 20.55. It is 59.18% from the current price. The 52-week Low is 7.82. It is -39.43% from current price.

There are some statistics of STML. It is has market cap $410.55 million. The share outstanding is 31.80 million. The average volume is 544711. The percent of top 15 Institution holding is 99.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of STML is -123.50%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of STML is -99.06%.


Tags:

Share this post